X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cholangiocarcinoma (14) 14
cancer (10) 10
humans (10) 10
index medicus (9) 9
chemotherapy (7) 7
apoptosis (6) 6
bile duct neoplasms - pathology (6) 6
cell line, tumor (6) 6
cholangiocarcinoma - pathology (6) 6
expression (6) 6
oncology (6) 6
bile duct neoplasms - genetics (5) 5
cholangiocarcinoma - genetics (5) 5
analysis (4) 4
pharmacology & pharmacy (4) 4
studies (4) 4
animals (3) 3
bile (3) 3
bile duct neoplasms - drug therapy (3) 3
bile ducts, intrahepatic - pathology (3) 3
cancer therapies (3) 3
cell survival - drug effects (3) 3
cholangiocarcinoma - drug therapy (3) 3
cytotoxicity (3) 3
gemcitabine (3) 3
intrahepatic cholangiocarcinoma (3) 3
liver (3) 3
liver fluke (3) 3
metastasis (3) 3
migration (3) 3
oxidative stress (3) 3
tumor proteins (3) 3
activation (2) 2
antioxidants (2) 2
apoptosis - drug effects (2) 2
bile duct (2) 2
bile ducts, intrahepatic - drug effects (2) 2
blotting, western (2) 2
cell adhesion & migration (2) 2
cell cycle (2) 2
cell death (2) 2
cell growth (2) 2
cell lines (2) 2
cell movement - drug effects (2) 2
cell proliferation (2) 2
cell proliferation - drug effects (2) 2
chemosensitizing effect (2) 2
cholangiocarcinoma - enzymology (2) 2
cholangiocarcinoma - metabolism (2) 2
cytochrome (2) 2
cytochrome c (2) 2
deoxycytidine - analogs & derivatives (2) 2
deoxycytidine - pharmacology (2) 2
dicoumarol (2) 2
dna-damage (2) 2
dose-response relationship, drug (2) 2
enzymes (2) 2
focal adhesion kinase (2) 2
gastroenterology & hepatology (2) 2
gene expression (2) 2
glutathione - metabolism (2) 2
growth (2) 2
infections (2) 2
inhibition (2) 2
medicine, research & experimental (2) 2
metformin (2) 2
mitochondria (2) 2
molecular-mechanisms (2) 2
nf-kappa b - metabolism (2) 2
nrf2 (2) 2
nuclear nonproliferation (2) 2
opisthorchis viverrini (2) 2
oxidation-reduction (2) 2
poor-prognosis (2) 2
prevention (2) 2
proteins (2) 2
reactive oxygen species - metabolism (2) 2
research (2) 2
risk factors (2) 2
stat3 (2) 2
stat3 transcription factor - metabolism (2) 2
tumor-growth (2) 2
tumors (2) 2
up-regulation (2) 2
1-phosphatidylinositol 3-kinase (1) 1
60 applied life sciences (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
aberration (1) 1
acids (1) 1
adherent cells (1) 1
adhesion (1) 1
adolescent (1) 1
akt protein (1) 1
ampk (1) 1
animal tissues (1) 1
anticancer properties (1) 1
antimetabolites, antineoplastic - pharmacology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e34994
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2010, Volume 16, Issue 19, pp. 2362 - 2370
Journal Article
Life Sciences, ISSN 0024-3205, 01/2019, Volume 217, pp. 155 - 163
Metformin (Met), an essential antidiabetic agent, shows antitumor activity in some cancers. A previous study showed that Met enhanced cytotoxic activity of... 
Metformin | GSH redox | Nrf2 | Cholangiocarcinoma | Chemosensitizing effect | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | NETWORK | CANCER | GEMCITABINE | PERMEABILITY TRANSITION | REDOX | PHARMACOLOGY & PHARMACY | HEME OXYGENASE-1 | UP-REGULATION | EXPRESSION | MOLECULAR-MECHANISMS | Index Medicus
Journal Article
Drug Metabolism and Pharmacokinetics, ISSN 1347-4367, 01/2017, Volume 32, Issue 1, p. S84
Journal Article
Drug Metabolism and Pharmacokinetics, ISSN 1347-4367, 01/2017, Volume 32, Issue 1, pp. S84 - S84
Journal Article
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2014, Volume 15, Issue 12, pp. 5071 - 5076
Cholangiocarcinoma (CCA) is one of the aggressive cancers with a very poor prognosis. Several efforts have been made to identify and develop new agents for... 
JAK/STAT3 | Luteolin | Migration | Cholangiocarcinoma | Cell cycle | Apoptosis | ONCOLOGY | cell cycle | GROWTH | KINASE | migration | apoptosis | SUPPRESSION | cholangiocarcinoma | CANCER | MODULATION
Journal Article
Cancer Discovery, ISSN 2159-8274, 10/2017, Volume 7, Issue 10, pp. 1116 - 1135
Journal Article
Tropical Journal of Pharmaceutical Research, ISSN 1596-5996, 07/2018, Volume 17, Issue 7, pp. 1337 - 1343
Purpose: To investigate the antitumor effect of candidone extracted from Derris indica, against human cholangiocarcinoma (CCA) cells. Methods: Candidone was... 
Cytotoxicity | Candidone | Cholangiocarcinoma | Derris indica | Apoptosis | DIAGNOSIS | INTRAHEPATIC CHOLANGIOCARCINOMA | PATHWAY | GENES | PHARMACOLOGY & PHARMACY | PROLIFERATION | CANCER CHEMOPREVENTION
Journal Article
Oncology Letters, ISSN 1792-1074, 06/2017, Volume 13, Issue 6, pp. 4540 - 4548
We previously reported that upregulation of NAD(P) H: quinone oxidoreductase 1 (NQO1) in cholangiocarcinoma (CCA; a fatal bile duct cancer) was associated with... 
Cell proliferation | NAD(P)H:quinone oxidoreductase 1 | Migration | Cholangiocarcinoma | Cell cycle | CANCER-CELLS | NQO1 EXPRESSION | APOPTOSIS | NAD(P)H-QUINONE OXIDOREDUCTASE-1 | cell proliferation | MECHANISM | cell cycle | PANCREATIC-CANCER | cholangio-carcinoma | GEMCITABINE | ONCOLOGY | POOR-PROGNOSIS | migration | INDUCED CYTOTOXICITY | DICOUMAROL
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 2010, Volume 48, Issue 8, pp. 2265 - 2272
Journal Article
Anticancer Research, ISSN 0250-7005, 12/2015, Volume 35, Issue 12, pp. 6639 - 6653
Background/Aim: Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare autosomal dominant disorder characterized by fumarate hydratase (FH) gene... 
Journal Article
Asian Pacific journal of cancer prevention : APJCP, ISSN 1513-7368, 2014, Volume 15, Issue 12, pp. 5071 - 5076
Cholangiocarcinoma (CCA) is one of the aggressive cancers with a very poor prognosis. Several efforts have been made to identify and develop new agents for... 
Journal Article